Research

Mixed

Bariatric surgery significantly reduces all-cause mortality, disease-specific mortality (cancer, cardiovascular, diabetes), and major adverse cardiovascular events (MACEs) in patients with severe obesity compared to matched non-surgical controls.

For individuals with severe obesity, bariatric surgery is a highly effective intervention for reducing the risk of death from cancer, heart disease, and diabetes, as well as preventing major cardiovascular events. It offers superior long-term outcomes compared to lifestyle changes alone for this population. Patients should discuss these benefits with their healthcare providers to determine if they are candidates.

GoodSupportsHIGH confidence
Bariatric surgery was associated with a lower risk of disease-specific mortality including cancer mortality [hazard ratio with 95% confidence interval: 0.46 (0.37–0.58)], cardiovascular mortality [0.38 (0.29–0.50)], and diabetes mortality [0.25 (0.11–0.57)]. Bariatric surgery was associated with a lower incidence of MACEs [0.58 (0.51–0.66)] and its components including all-cause mortality [0.52 (0.47–0.58)]...
Beibei Cui et al. · International Journal of Surgery · 2023

Why this rating

High-quality meta-analysis of 40 matched cohort studies with large sample sizes, though observational design limits causal inference compared to RCTs.

Source

Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies

Beibei Cui et al. · International Journal of Surgery · 2023

DOI 10.1097/js9.0000000000000066

Meta-analysis · 40 studiesCited 20×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →